vTv Therapeutics (VTVT) Tops Q1 EPS by 165c

vTv Therapeutics (NASDAQ: VTVT) reported Q1 EPS of $1.65. Revenue for the quarter came in at $36.84 million.

For earnings history and earnings-related data on vTv Therapeutics (VTVT) click here.

You May Also Be Interested In

• Oracle (ORCL) PT Lowered to $290 at Jefferies
• Morgan Stanley Starts ARCHION Corp (543A:JP) at Equalweight
• Palo Alto Networks (PANW) Tops Q4 EPS by 4c, Offers Guidance